Background and Purpose: Spontaneous echo contrast is a dynamic smokelike signal that is detected by transesophageal echocardiography in patients with stasis of blood in the left atrium. We designed this study to determine if spontaneous echo contrast is associated with an increased risk of previous stroke or peripheral embolism.
L eft atrial spontaneous echo contrast (SEC) is a dynamic smokelike signal that is detected by transesophageal echocardiography (TEE) in patients with stasis of blood in the left atrium. The most common conditions predisposing to left atrial SEC are atrial fibrillation (AF) and mitral stenosis.1-3 Studies in dogs indicate that SEC represents intracardiac erythrocyte or platelet microaggregates,4-6 which suggests that SEC may be a precursor of thrombus. These findings have prompted studies to determine the association of SEC and previous stroke or peripheral embolism.237-1' These studies suggest that left atrial SEC is associated with an increased risk of previous stroke; however, traditional risk factors for stroke were not evaluated systematically in any of these studies. Furthermore, the control groups in most of these studies included patients at low risk for thromboembolism, and the results of brain and cerebrovascular imaging in patients with stroke and SEC were not described.
The aims of this study were (1) to determine if left atrial SEC is associated with an increased risk of previous stroke or peripheral embolism independent of vascular and echocardiographic risk factors for thromboembolism and (2) Table 1 . The rates of traditional risk factors for stroke were the same in both groups, yet 9 (21%) of 42 patients with left atrial SEC had a stroke (7 patients) or peripheral embolism (2 patients) compared with only 1 (3%) of 40 patients without SEC (P<.02; relative risk, 10.6; 95% confidence interval, 1.3 to 88.4). All strokes and peripheral emboli in both groups occurred within 6 weeks of TEE.
The frequency of two echocardiographic features was significantly different (P<.05) in the two groups. Mean left atrial size was significantly larger in patients with left atrial SEC, and severe mitral regurgitation was significantly more common in patients without left atrial SEC. Left ventricular dysfunction tended to be more common in patients with SEC (P=.05). The frequency of left atrial thrombus was not different in the two groups.
The frequency of the underlying cardiac abnormalities in patients with SEC and in patients without SEC is shown in Table 2 . The group without SEC had a higher percentage of patients with nonvalvular AF, and the group with SEC had a higher percentage of patients with valvular AF (ie, AF and mitral stenosis). Of 9 patients with SEC who had a stroke or peripheral embolism, 6 had nonvalvular AF, 1 had mitral stenosis and AF, and 2 had dilated cardiomyopathy without AF or mitral stenosis. The only patient without SEC who Table 2 . Twenty-six (62%) of 42 patients with SEC and 20 (50%) of 40 patients without SEC were being treated with either warfarin or aspirin (P=.37). Of 9 patients with SEC who had a stroke or peripheral embolism, 3 were being treated with warfarin, 1 was treated with aspirin, and 5 were treated with neither. Two of the 3 patients treated with warfarin were inadequately anticoagulated at the onset of their thromboembolic events: one patient with nonvalvular AF had a stroke a few days after stopping warfarin treatment in preparation for oral surgery, and another patient with mitral stenosis and AF had a subtherapeutic prothrombin time when he presented with a peripheral embolus. The only patient without SEC who had a stroke had nonvalvular AF and was not taking either warfarin or aspirin. In the primary analysis comparing patients with and without SEC, we found that left atrial SEC was significantly associated with previous stroke or peripheral embolism, left atrial enlargement, and left ventricular dysfunction (trend only). In addition, severe mitral regurgitation was associated with the absence of SEC. There was some imbalance, however, in the frequency of the underlying cardiac abnormalities in the groups with and without SEC ( Table 2 ). The group without SEC had a higher percentage of patients with nonvalvular AF, and the group with SEC had a higher percentage of patients with valvular AF. These data probably reflect the fact that a minority of patients with nonvalvular AF have SEC," whereas patients with coexistent AF and mitral stenosis are more likely to have SEC. The higher frequency of coexistent AF and mitral stenosis in patients with SEC did not correlate directly with the higher rate of thromboembolism in this group: only one of the nine patients with SEC and thromboembolism had coexistent AF and mitral stenosis (Table 2) .
In a secondary analysis comparing patients with and without stroke or peripheral embolism, we found that SEC was the only factor associated with stroke or peripheral embolism. However, the power of the study to detect differences in the frequency of some factors (eg, hypertension, myocardial infarction, and severe mitral regurgitation) was low (Table 3) .
Although left atrial enlargement was associated with SEC, it was not associated with previous stroke or peripheral embolism. In fact, mean left atrial size was smaller in patients with stroke compared with patients without stroke. Other studies have shown that left atrial enlargement is not associated with an increased risk of stroke in patients with nonvalvular AF.16 '17 Severe mitral regurgitation was associated with the absence of left atrial SEC in our study. Most,2'3"1 but not all,10 previous studies of SEC have shown the same result. Presumably, high-flow regurgitant jets of blood from the left ventricle prevent stasis of blood in the left atrium in patients with mitral regurgitation. The association of severe mitral regurgitation and the absence of left atrial SEC suggest the possibility that severe mitral regurgitation may protect against stroke in patients with AF or mitral stenosis. Although we did not find a statistical association between severe mitral regurgitation and the absence of stroke, the power of the study to detect such a difference was low. Of note is that none of the 10 patients who had a stroke or peripheral embolism had severe mitral regurgitation. We cannot provide definite evidence that cardioembolism was the mechanism of stroke in our seven patients with SEC because only two patients underwent vascular imaging. In these two patients, the absence of large artery occlusive disease proximal to large cortical infarcts supports the diagnosis of cardioembolism. In the other five patients who did not undergo vascular imaging, the brain-imaging features suggest that cardioembolism was the likely mechanism of stroke in four of these patients. These features were multiple infarcts in different vascular distributions and wedge-shaped infarcts involving the cerebral cortex.20 '21 Although this study was not designed to determine effective therapy for preventing stroke in patients with left atrial SEC, the therapeutic data are of interest ( The results of this study and other retrospective studies3,9"1' suggest that TEE may be useful for stratifying cardioembolic risk in patients with nonvalvular AF. In our subgroup analysis of patients with nonvalvular AF, patients with left atrial SEC were 27 times more likely to have had a previous stroke or peripheral embolism than patients without left atrial SEC (95% confidence interval for relative risk, 2.7 to 267.8). Our study population, however, consisted of patients referred for TEE and is probably not representative of a typical cross section of patients with nonvalvular AF. Prospective studies using TEE in nonselected patients are needed to establish definitively that left atrial SEC is a major risk factor for stroke in patients with nonvalvular AF.
